1) 6,000 amputations take place in England each year due to diabetes complications costing £600M. The document proposes an intelligent care plan mobile application to help diabetic patients better monitor and control their health.
2) The application would provide daily monitoring of key health risks, education, social support and access to clinical care to help patients bring their diabetes under control to prevent complications like foot ulcers and amputations.
3) Currently treating diabetic patients with severe complications costs tens of times more than non-diabetic patients, ranging from £50,000 to £289,831 per operation. The proposed application aims to provide integrated care for £1480 per patient per year to achieve better outcomes at lower costs
From High Hopes to HITECH: Money and Meaningful Use. Centricity Healthcare User Group. This presentation covers meaningful use, IT Adoption, interoperability, network effects, transparency and better outcomes from the use of Health Information Technology.
Health Datapalooza IV: June 3rd-4th, 2013
Sanofi US Data Design Diabetes Demo Day
The “2013 Sanofi US Data Design Diabetes Innovation Challenge – Prove It!” invites innovators to develop solutions that use or produce data for decision-making to help improve health outcomes for people living with diabetes. Through baseline knowledge models, evidence-based practice, or predictive analysis, Prove It! asks innovators to think creatively about how to effectively harness data to address diabetes in the United States. During this hour, the final teams will live pitch their product to a panel of judges on the Main Stage with one winner to be presented with $100,000 on Tuesday, June 4.
Presenter: Sara Holoubek, Chief Executive Officer, Luminary Labs
Nutrition Solutions | eHealth HUB Solution Match ReporteHealth HUB
eHealth HUB organized a Solution Match service for AXA, looking for nutrition solutions, able to support healthier eating habits for their customers and promote general well-being. This Solution Match Report displays the results of eHealth HUB - AXA Call for applications, presenting in a synthetical way all the solutions and their main features.
This report makes available Remote Monitoring Solutions presented by 71 companies who replied to the Hospital Bernal Solution Match Call, launched by eHealth HUB in February 2017.
From High Hopes to HITECH: Money and Meaningful Use. Centricity Healthcare User Group. This presentation covers meaningful use, IT Adoption, interoperability, network effects, transparency and better outcomes from the use of Health Information Technology.
Health Datapalooza IV: June 3rd-4th, 2013
Sanofi US Data Design Diabetes Demo Day
The “2013 Sanofi US Data Design Diabetes Innovation Challenge – Prove It!” invites innovators to develop solutions that use or produce data for decision-making to help improve health outcomes for people living with diabetes. Through baseline knowledge models, evidence-based practice, or predictive analysis, Prove It! asks innovators to think creatively about how to effectively harness data to address diabetes in the United States. During this hour, the final teams will live pitch their product to a panel of judges on the Main Stage with one winner to be presented with $100,000 on Tuesday, June 4.
Presenter: Sara Holoubek, Chief Executive Officer, Luminary Labs
Nutrition Solutions | eHealth HUB Solution Match ReporteHealth HUB
eHealth HUB organized a Solution Match service for AXA, looking for nutrition solutions, able to support healthier eating habits for their customers and promote general well-being. This Solution Match Report displays the results of eHealth HUB - AXA Call for applications, presenting in a synthetical way all the solutions and their main features.
This report makes available Remote Monitoring Solutions presented by 71 companies who replied to the Hospital Bernal Solution Match Call, launched by eHealth HUB in February 2017.
Dr. Dan Mingle's Overview of the 2015 Medicare Final RuleMingle Analytics
Dr. Dan Mingle, CEO of Mingle Analytics, reviews the 2015 Medicare Final Rule. Need help avoiding CMS payment adjustments and penalties? PQRS Solutions(TM), software and services by Mingle Analytics(TM), can help. Learn more at http://www.pqrssolutions.com
1) Optimising business process for telehealth services
2) Business process management in healthcare
3) Medical claim for healthcare (EDI 837)
4) Remote patients monitoring system
5) Noval drug approval for 2021 (FDA)
6) How covid-19 accelerated healthcare
Artificial Intelligence—Infinite Possibilities: Adam Hanina, AICure (Digital ...Jill Gilbert
How are Pharma and health systems using artificial intelligence to improve outcomes and lower costs? AiCure will present a live demonstration of how their AI platform will tackle a major challenge taxing the healthcare system — medication adherence. You’ll see how their technology will not only positively impact clinical trial success rates and improve patient behavior, but will also help reduce the costs attributed to our nationwide lack of medication compliance.
Vasco Da Gama 2015 Dublin The Effect of the Economic Crisis on the Irish Heal...DrWilliamBehan
Vasco Da Gama 2015 Dublin The Effect of the Economic Crisis on the Irish Health Systems and the Missed Opportunity of Promoting General Practice and Primary Care in favour of Overly Bureaucratic, Commoditised, Fragmented Corporate Healthcare and Public Servants Pay and Conditions
Medibank Managing Director speaks at Amercian Chamber of CommerceLaura Harris
Medibank Managing Director, George Savvides presented at the American Chamber of Commerce in Melbourne about Medibank’s approach to primary care and its integrated care pilots.
From the Nexus project showcase. Presented by Dr Martin Wilson, Clinical Leader I.T., Pegasus Health and Symon McHerron, CIO, Pegasus Health at HINZ 2014, 11 November 2014, 1.45pm, Plenary Room
Dying to Get High—Tackling the Opioid Epidemic (Digital Health Summit @ CES)Jill Gilbert
The CDC published that 78 people die each day from opioid abuse every day. How can tech innovators and addiction specialists reduce the fallout from this common, and much stigmatized, public health nightmare? Join leaders in pharma, digital health, and one of the largest hospitals in the U.S. for a timely discussion that is sure to make headlines.
Vasco Da Gama Dublin 2015 plenary 1 economic crisis introduction william behanDrWilliamBehan
Vasco Da Gama 2015 Dublin The Effect of the Economic Crisis on European Health Systems and the Missed Opportunity of Promoting General Practice and Primary Care in favour of Overly Bureaucratic, Commoditised, Fragmented Corporate Healthcare
Hawkins House Presentation on Irish Primary care Statistics
Thursday 24th January 2013 @ 3 pm by GP Dr William Behan to senior HSE and Department of Health staff based on Dr William Behans 2013 FEMPI (Financial Emergency Measures in the Public Interest Act) submission
Dr. Dan Mingle's Overview of the 2015 Medicare Final RuleMingle Analytics
Dr. Dan Mingle, CEO of Mingle Analytics, reviews the 2015 Medicare Final Rule. Need help avoiding CMS payment adjustments and penalties? PQRS Solutions(TM), software and services by Mingle Analytics(TM), can help. Learn more at http://www.pqrssolutions.com
1) Optimising business process for telehealth services
2) Business process management in healthcare
3) Medical claim for healthcare (EDI 837)
4) Remote patients monitoring system
5) Noval drug approval for 2021 (FDA)
6) How covid-19 accelerated healthcare
Artificial Intelligence—Infinite Possibilities: Adam Hanina, AICure (Digital ...Jill Gilbert
How are Pharma and health systems using artificial intelligence to improve outcomes and lower costs? AiCure will present a live demonstration of how their AI platform will tackle a major challenge taxing the healthcare system — medication adherence. You’ll see how their technology will not only positively impact clinical trial success rates and improve patient behavior, but will also help reduce the costs attributed to our nationwide lack of medication compliance.
Vasco Da Gama 2015 Dublin The Effect of the Economic Crisis on the Irish Heal...DrWilliamBehan
Vasco Da Gama 2015 Dublin The Effect of the Economic Crisis on the Irish Health Systems and the Missed Opportunity of Promoting General Practice and Primary Care in favour of Overly Bureaucratic, Commoditised, Fragmented Corporate Healthcare and Public Servants Pay and Conditions
Medibank Managing Director speaks at Amercian Chamber of CommerceLaura Harris
Medibank Managing Director, George Savvides presented at the American Chamber of Commerce in Melbourne about Medibank’s approach to primary care and its integrated care pilots.
From the Nexus project showcase. Presented by Dr Martin Wilson, Clinical Leader I.T., Pegasus Health and Symon McHerron, CIO, Pegasus Health at HINZ 2014, 11 November 2014, 1.45pm, Plenary Room
Dying to Get High—Tackling the Opioid Epidemic (Digital Health Summit @ CES)Jill Gilbert
The CDC published that 78 people die each day from opioid abuse every day. How can tech innovators and addiction specialists reduce the fallout from this common, and much stigmatized, public health nightmare? Join leaders in pharma, digital health, and one of the largest hospitals in the U.S. for a timely discussion that is sure to make headlines.
Vasco Da Gama Dublin 2015 plenary 1 economic crisis introduction william behanDrWilliamBehan
Vasco Da Gama 2015 Dublin The Effect of the Economic Crisis on European Health Systems and the Missed Opportunity of Promoting General Practice and Primary Care in favour of Overly Bureaucratic, Commoditised, Fragmented Corporate Healthcare
Hawkins House Presentation on Irish Primary care Statistics
Thursday 24th January 2013 @ 3 pm by GP Dr William Behan to senior HSE and Department of Health staff based on Dr William Behans 2013 FEMPI (Financial Emergency Measures in the Public Interest Act) submission
Nemaura Medical is developing non-invasive and minimally invasive wearable diagnostic devices,
coupled with artificial intelligence capabilities for digital healthcare. The company’s first product,
which is CE approved and undergoing commercial launch, is the sugarBEAT® non-invasive
continuous glucose monitoring device and BEAT®diabetes digital healthcare platform.
sugarBEAT® is a non-invasive and flexible continuous glucose monitor (CGM) providing
actionable insights derived from real-time glucose measurements and daily glucose trend data,
which help people with Type 1 or Type 2 diabetes and prediabetes respectively to better manage,
reverse and prevent the onset of diabetes. BEAT®diabetes is a health subscription service
providing 1-on-1 lifestyle coaching and behavior change recommendations driven by personalized
data provided by sugarBEAT®. Insulin users can also adjunctively use sugarBEAT® for insulin
dosage purposes when calibrated by a finger stick reading. sugarBEAT® is intended to be worn
during waking hours and consists of a daily disposable adhesive skin-patch connected to a
rechargeable transmitter, with an app displaying glucose readings at five-minute intervals.
Dr Ashish Jha: lessons from organisational changeNuffield Trust
Dr Ashish Jha, Harvard School of Public Health, presenting at the Nuffield Trust Health Policy Summit, explores how change happens, drawing on examples from Accountable Care Organisations in the USA.
A benefits case study describing how Diabetes UK has used HSCIC's data and statistical outputs to inform the Putting Feet First campaign. https://www.diabetes.org.uk/Get_involved/Campaigning/Our-campaigns/Putting-feet-first/
National Diabetes Audit (NDA) Care Processes and Treatment Targets 2013-15 Laura Fargher
The National Diabetes Audit (NDA) continues to provide a comprehensive view of Diabetes Care in England and Wales and measures the effectiveness of diabetes healthcare against NICE Clinical Guidelines and NICE Quality Standards, in England and Wales.
This national report presents the key findings and recommendations on care processes and treatment target achievement rates from 2013-2015 in all age groups in England and Wales along with information on offers and attendance for structured education places.
Improving quality of care, using existing assets better and reducing medical ...NHS England
Expo is the most significant annual health and social care event in the calendar, uniting more NHS and care leaders, commissioners, clinicians, voluntary sector partners, innovators and media than any other health and care event.
Expo 15 returned to Manchester and was hosted once again by NHS England. Around 5000 people a day from health and care, the voluntary sector, local government, and industry joined together at Manchester Central Convention Centre for two packed days of speakers, workshops, exhibitions and professional development.
This year, Expo was more relevant and engaging than ever before, happening within the first 100 days of the new Government, and almost 12 months after the publication of the NHS Five Year Forward View. It was also a great opportunity to check on and learn from the progress of Greater Manchester as the area prepares to take over a £6 billion devolved health and social care budget, pledging to integrate hospital, community, primary and social care and vastly improve health and well-being.
More information is available online: www.expo.nhs.uk
Read more about what information is available to help you and your organisation when managing long term conditions.
The HSCIC discussed this topic at HETT 2014, with reference to the following key areas:
- The national picture
- Population level health information
- Mental health minimum dataset
- CCG outcomes indicator set
- Quality and outcomes framework (QOF)
- The national diabetes audit
- Prescribing information
How Pharma Can Use Digital Health to Drive Value | A Medullan WebinarMedullan
With the shift to value, healthcare payers are insisting that pharmaceutical manufacturers deliver real world evidence of their drug’s efficacy before being allowed on formulary. The cost of new specialty treatments has forced companies to bolster and go beyond clinical trial, proving that their drugs improve health outcomes and reduce the cost of care with real world evidence.
So how do pharmaceutical companies gather these data points and what kind of digital tools should they use?
Report Back from SGO 2024: What’s the Latest in Cervical Cancer?bkling
Are you curious about what’s new in cervical cancer research or unsure what the findings mean? Join Dr. Emily Ko, a gynecologic oncologist at Penn Medicine, to learn about the latest updates from the Society of Gynecologic Oncology (SGO) 2024 Annual Meeting on Women’s Cancer. Dr. Ko will discuss what the research presented at the conference means for you and answer your questions about the new developments.
Flu Vaccine Alert in Bangalore Karnatakaaddon Scans
As flu season approaches, health officials in Bangalore, Karnataka, are urging residents to get their flu vaccinations. The seasonal flu, while common, can lead to severe health complications, particularly for vulnerable populations such as young children, the elderly, and those with underlying health conditions.
Dr. Vidisha Kumari, a leading epidemiologist in Bangalore, emphasizes the importance of getting vaccinated. "The flu vaccine is our best defense against the influenza virus. It not only protects individuals but also helps prevent the spread of the virus in our communities," he says.
This year, the flu season is expected to coincide with a potential increase in other respiratory illnesses. The Karnataka Health Department has launched an awareness campaign highlighting the significance of flu vaccinations. They have set up multiple vaccination centers across Bangalore, making it convenient for residents to receive their shots.
To encourage widespread vaccination, the government is also collaborating with local schools, workplaces, and community centers to facilitate vaccination drives. Special attention is being given to ensuring that the vaccine is accessible to all, including marginalized communities who may have limited access to healthcare.
Residents are reminded that the flu vaccine is safe and effective. Common side effects are mild and may include soreness at the injection site, mild fever, or muscle aches. These side effects are generally short-lived and far less severe than the flu itself.
Healthcare providers are also stressing the importance of continuing COVID-19 precautions. Wearing masks, practicing good hand hygiene, and maintaining social distancing are still crucial, especially in crowded places.
Protect yourself and your loved ones by getting vaccinated. Together, we can help keep Bangalore healthy and safe this flu season. For more information on vaccination centers and schedules, residents can visit the Karnataka Health Department’s official website or follow their social media pages.
Stay informed, stay safe, and get your flu shot today!
Basavarajeeyam is an important text for ayurvedic physician belonging to andhra pradehs. It is a popular compendium in various parts of our country as well as in andhra pradesh. The content of the text was presented in sanskrit and telugu language (Bilingual). One of the most famous book in ayurvedic pharmaceutics and therapeutics. This book contains 25 chapters called as prakaranas. Many rasaoushadis were explained, pioneer of dhatu druti, nadi pareeksha, mutra pareeksha etc. Belongs to the period of 15-16 century. New diseases like upadamsha, phiranga rogas are explained.
New Directions in Targeted Therapeutic Approaches for Older Adults With Mantl...i3 Health
i3 Health is pleased to make the speaker slides from this activity available for use as a non-accredited self-study or teaching resource.
This slide deck presented by Dr. Kami Maddocks, Professor-Clinical in the Division of Hematology and
Associate Division Director for Ambulatory Operations
The Ohio State University Comprehensive Cancer Center, will provide insight into new directions in targeted therapeutic approaches for older adults with mantle cell lymphoma.
STATEMENT OF NEED
Mantle cell lymphoma (MCL) is a rare, aggressive B-cell non-Hodgkin lymphoma (NHL) accounting for 5% to 7% of all lymphomas. Its prognosis ranges from indolent disease that does not require treatment for years to very aggressive disease, which is associated with poor survival (Silkenstedt et al, 2021). Typically, MCL is diagnosed at advanced stage and in older patients who cannot tolerate intensive therapy (NCCN, 2022). Although recent advances have slightly increased remission rates, recurrence and relapse remain very common, leading to a median overall survival between 3 and 6 years (LLS, 2021). Though there are several effective options, progress is still needed towards establishing an accepted frontline approach for MCL (Castellino et al, 2022). Treatment selection and management of MCL are complicated by the heterogeneity of prognosis, advanced age and comorbidities of patients, and lack of an established standard approach for treatment, making it vital that clinicians be familiar with the latest research and advances in this area. In this activity chaired by Michael Wang, MD, Professor in the Department of Lymphoma & Myeloma at MD Anderson Cancer Center, expert faculty will discuss prognostic factors informing treatment, the promising results of recent trials in new therapeutic approaches, and the implications of treatment resistance in therapeutic selection for MCL.
Target Audience
Hematology/oncology fellows, attending faculty, and other health care professionals involved in the treatment of patients with mantle cell lymphoma (MCL).
Learning Objectives
1.) Identify clinical and biological prognostic factors that can guide treatment decision making for older adults with MCL
2.) Evaluate emerging data on targeted therapeutic approaches for treatment-naive and relapsed/refractory MCL and their applicability to older adults
3.) Assess mechanisms of resistance to targeted therapies for MCL and their implications for treatment selection
Recomendações da OMS sobre cuidados maternos e neonatais para uma experiência pós-natal positiva.
Em consonância com os ODS – Objetivos do Desenvolvimento Sustentável e a Estratégia Global para a Saúde das Mulheres, Crianças e Adolescentes, e aplicando uma abordagem baseada nos direitos humanos, os esforços de cuidados pós-natais devem expandir-se para além da cobertura e da simples sobrevivência, de modo a incluir cuidados de qualidade.
Estas diretrizes visam melhorar a qualidade dos cuidados pós-natais essenciais e de rotina prestados às mulheres e aos recém-nascidos, com o objetivo final de melhorar a saúde e o bem-estar materno e neonatal.
Uma “experiência pós-natal positiva” é um resultado importante para todas as mulheres que dão à luz e para os seus recém-nascidos, estabelecendo as bases para a melhoria da saúde e do bem-estar a curto e longo prazo. Uma experiência pós-natal positiva é definida como aquela em que as mulheres, pessoas que gestam, os recém-nascidos, os casais, os pais, os cuidadores e as famílias recebem informação consistente, garantia e apoio de profissionais de saúde motivados; e onde um sistema de saúde flexível e com recursos reconheça as necessidades das mulheres e dos bebês e respeite o seu contexto cultural.
Estas diretrizes consolidadas apresentam algumas recomendações novas e já bem fundamentadas sobre cuidados pós-natais de rotina para mulheres e neonatos que recebem cuidados no pós-parto em unidades de saúde ou na comunidade, independentemente dos recursos disponíveis.
É fornecido um conjunto abrangente de recomendações para cuidados durante o período puerperal, com ênfase nos cuidados essenciais que todas as mulheres e recém-nascidos devem receber, e com a devida atenção à qualidade dos cuidados; isto é, a entrega e a experiência do cuidado recebido. Estas diretrizes atualizam e ampliam as recomendações da OMS de 2014 sobre cuidados pós-natais da mãe e do recém-nascido e complementam as atuais diretrizes da OMS sobre a gestão de complicações pós-natais.
O estabelecimento da amamentação e o manejo das principais intercorrências é contemplada.
Recomendamos muito.
Vamos discutir essas recomendações no nosso curso de pós-graduação em Aleitamento no Instituto Ciclos.
Esta publicação só está disponível em inglês até o momento.
Prof. Marcus Renato de Carvalho
www.agostodourado.com
Dehradun #ℂall #gIRLS Oyo Hotel 9719300533 #ℂall #gIRL in Dehradun
Ipcp intro
1. Copyright Partnerships for Healthcare Improvement Ltd.
The Lean Start Up - Diabetic Care Plan (intelligent care plan iCP)
1
2. Copyright Partnerships for Healthcare Improvement Ltd. 2
Product
Strategy
Vision
6,000 amputations take place in England each
year at a cost of £600M. 80% of patients will
die within 5 years after major amputation. No
diabetic patient should ever suffer an
amputation ever again
Helping people achieve “controlled diabetes” will
prevent damages nerves, muscles, sweat glands and
circulation to feet and legs. Regular foot checks and
control of blood glucose, blood fats, and blood
pressure under control can prevent complications.
80,000 (2.5%) diabetics in England have for ulcers -
getting people to act on information and control their
diabetes we could reduce this to zero.
A patient centric mobile Diabetic Care Plan application
that provides daily monitoring of key risk factors via
wearable devices and gives patients the information,
the social support, motivation factors and access to
integrated clinical care that they need to bring their
diabetes quickly under control and hence prevent risks
of severe complications. So they can live a long
worry free life, free of morbidity and stress.
3. Copyright Partnerships for Healthcare Improvement Ltd. 3
DRG Description Total cost for all
hospitals
Cost per patient with
complication
Cases
K01A Operation room procedures for diabetic
complications with catastrophic complication or
co morbidity
£25,138,714 £259,162 97
K60B Diabetes without catastrophic or severe
complications or co morbidity
£3,710,952 £2,072 1791
K60A Diabetes with catastrophic or severe
complications or co morbidity
£1,868,796 £5,106 366
F11A Amputation for circulatory system except upper
limb and toe with catastrophic complications or
comorbidities
£1,751,309 £35,741 49
K01B Operation room procedures for diabetic
complications without catastrophic complication
or comorbidity
£925,912 £8,903 104
F11B Amputation for circulatory system except upper
limb and toe without catastrophic complications
or comorbidities
£501,640 £12,541 40
F13A Upper limb and toe amputation for circulatory
system disorders with catastrophic or severe
complications or co morbidities
£443,556 £11,988 37
F13B Upper limb and toe amputation for circulatory
system disorders without catastrophic or severe
complications or co morbidities
£285,448 £9,208 31
Total £34,626,327 2515
To provide current acute based service on average costs £13,767 per patient in 2010. This is tens times the
cost for non diabetic patient. But average costs mask the massive cost of treating Diabetic patients with
catastrophic conditions.
18 Irish Hospitals: 2011 Treatment Costs for Diabetics w/severe complications
4. Copyright Partnerships for Healthcare Improvement Ltd. 4
£50,000 to £289,831/operation
for a patient
with severe complications
£1480/yr/patient
world class integrated care
A new model of care is better and cheaper
Current StateFuture State
5. Copyright Partnerships for Healthcare Improvement Ltd.
Carry out Personal
Health Assessment
Motivate & Support
Patient to follow
care plan
Educate Patient
to make necessary
changes
Create
Personalised
Care Plan
Continuously
Monitor key
health indicators
Identify specific
health risks
Set specific achievable
health goals
Measure Progress &
early warning of worsening conditions
Provide knowledge to
change behaviours
Improve outcomes
and reduce risks
In control of your
health
Improved health
Co-ordinated proactive
care at lower cost
6. Copyright Partnerships for Healthcare Improvement Ltd. 6
Using iCP App then no diabetic patient should ever suffer an amputation ever again
Growth HypothesisValue Hypothesis
1
Following a blood test Patient will want information on risk
factors
2
If identified as high risk then they will want to control blood
pressure and blood glucose
3
they will check their readings daily via a tablet to see how
risk factors are being reduced
4
they will want to reduce their weight to meet target via diet
and exercise
5
monitoring activity and exercise will encourage use of the
application
6 Reduce Wait circumference to recommended levels
7 reduce HbA1C to recommend levels
8 reduce total cholesterol to recommended levels
9 reduce blood pressure to recommended levels
10
reduced count and severity of foot ulcers and increased
sensitivity in feet
11 reduced hospital admissions
12 no hospital admissions
1. send invite email to recently diagnosed patient (Xpert
health training attendees) with diet plan
2. send invite to health check patients (Gp Lists) with login
details set up to retrieve blood test results
3. send email to at risk patients from GP list with login
details at next home visit to order BP and BG monitoring
equipment
4. logins
5. Order monitoring devices
6. take out risk assessment
7. Daily visits to view results
8. Try out new feature
9. Add friend to share information
10. Participate in blog
11. Share record with clinical team
12. Buy more devices
13. Pay for tailored care plan
14. Donate data
acquisitionretentionrevenueactivationreferral
7. Copyright Partnerships for Healthcare Improvement Ltd. 7
Experiments and Minimum Viable Products
no MVP Test Metric
1
Website with login to obtain test results
and written guidance
registration rate
2
Login in to obtain Personalised Health
score after adding some data
activation rate
3
Buy Blood pressure and blood glucose
monitoring and tablet devices via a long
term lease
registration rate, activation rate, retention rate,
revenue rate
4
Buy Blood pressure and blood glucose
monitoring and tablet devices via a on-
off purchase
registration rate, activation rate, retention rate,
revenue rate
5
Provide limited my charts product to
monitor BP, BG, Weight,
registration rate, activation rate, retention rate,
6
Add medicine tracking for glucose and
BP control, plus activity tracker
registration rate, activation rate, retention rate,
referral rate, revenue, lifetime value
7
Provide Food Carbohydrate counter and
record each meal on nutrient wheel
registration rate, activation rate, retention rate,
referral rate, revenue, lifetime value
8 Record food taken via snapchat
functionality
registration rate, activation rate, retention rate,
referral rate, revenue, lifetime value
9 Add foot pictures and time line with
annotation on sensitive measure
registration rate, activation rate, retention rate,
referral rate, revenue, lifetime value
10 add journal functionality
registration rate, activation rate, retention rate,
referral rate, revenue, lifetime value
11 add social networking
registration rate, activation rate, retention rate,
referral rate,
12 Add moderator to social networking and
advisor
registration rate, activation rate, retention rate,
referral rate
13 add Xpert training videos registration rate, activation rate, retention rate,
referral rate, revenue, lifetime value
14 donate my data
registration rate, activation rate, retention rate,
referral rate, revenue, lifetime value
acquisitionretentionrevenueactivationreferral
8. Copyright Partnerships for Healthcare Improvement Ltd. 8
Kanban of work in progress
Backlog / Design In Progress Built Validated
acquisitionretentionrevenueactivationreferral
9. Copyright Partnerships for Healthcare Improvement Ltd. 9
Diabetic Retinopathy - all diabetics over the age of 12 years are
offered annual eye screening in the UK, and effective treatment
reduces eye deterioration by 33.33% (2.5 Million people ww have
diabetic caused blindness)
Kidney disease a simple urine test detects early signs and early
treatment prevents risk of developing disease or at least puts off need
for dialysis by 15 to 20 years (incidence is one third of diabetics)
High blood pressure and diabetes increase risk of stroke by 200%.
Effective BP control reduces risk of stroke by 33.33%
50% of diabetics also have CVD, effective treatment reduces chance of
heart attack by 50%
15 to 40 times more likely to suffer lower limb amputation, diabetic
foot examination and treatment of foot ulcers can prevent amputations
Health screening services provide very effective prevention
10. Copyright Partnerships for Healthcare Improvement Ltd. 10
Available to all people aged 40-70 years old for Diabetes and
Cardiovascular risk repeated every 5 years
HbA1c test measures the average blood glucose levels over a period of
10 weeks*
When detected early then a 1% reduction in HBA1c levels can translate
into a 30% reduction in number of complications such as eye disease
and nerve damage
16% drop in the number of complications such as heart disease(21, 22)
Advantages of using HBA1c tests are:
Test is conducted on the spot without need for fasting and results are
immediate
It is a highly reliable test with low % of false negatives (that is they test
negative when they have diabetes)
Diabetic Screening a UK success story
11. Copyright Partnerships for Healthcare Improvement Ltd. 11
Target Measures
Normal Risk High Risk
BMI 18.5 to 24.9 25 to 29.9 > 30
Waist
Circumference
<94 cms (M), 80
cms (F)
94-102 (M),
80-88 (F)
>102 (M), 88 (F)
Blood Glucose
(mmol/l)
fasting < 6.0
Pre meal below
5.9
2 hours post
meal below 7.8
HbA1c (mmol/
mol) average
blood glucose
20 to 41
(normal|)
42 to 47 (pre
diabetes)
48 and above
(diabetes)
Blood pressure below 130/80 below 140/90 Above 140/90
Total
Cholesterol
(mmol/l)
no current
recommendation
12. Copyright Partnerships for Healthcare Improvement Ltd. 12
Screen Shots for Prototype Intelligent Care Plan Application for DMTII
13. Copyright Partnerships for Healthcare Improvement Ltd. 13
Risk of amputation (macrovascular complications) is calculated
from 4 significant predictors
1. Waist circumference
2. Systolic Blood Pressure (mmHg)
3. Total Serum Cholesterol (mmol/L)
4. Whole Blood Haemoglobin A1c Level (%)
and we will want to track first sign of foot ulcers and each occurrence
No Development Risk
Very High
Development Risk
Moderate
Development Risk
Low Development Risk
High
Development Risk
Diabetes Complication
Risk Index (DCRI)
Diabetic Type 2 Risk Assessment Model